News Daily News Trials of New Cancer Drugs Failing to Address Potential CV Risks Todd Neale February 10, 2020
News Daily News Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis Caitlin E. Cox February 07, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Conference News ISET 2020 PERT Data Emerge, Though the Exact Strategy Isn’t a Done Deal Caitlin E. Cox January 30, 2020
News Daily News Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol Yael L. Maxwell January 28, 2020
News Daily News Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA Michael O'Riordan January 21, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events Shelley Wood January 20, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets Yael L. Maxwell December 26, 2019
News Daily News CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials Caitlin E. Cox December 11, 2019
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Daily News ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up Caitlin E. Cox December 05, 2019